Abbott Laboratories June 15th Short Interest Update

Abbott Laboratories (NYSE:ABT), A reduction of 788,006 shares or 1.5% was observed in the short interest of Abbott Laboratories The interest on June 15,2016 came in at 52,754,358 shares and as per the average daily trading of 10,009,575 shares, the days to cover are 5. The reduced interest is 3.6% of the floated shares. The data of May 31,2016 put the interest at 53,542,364 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.

Abbott Laboratories (NYSE:ABT): The stock opened at $38.37 on Friday but the bulls could not build on the opening and the stock topped out at $38.56 for the day. The stock traded down to $37.91 during the day, due to lack of any buying support eventually closed down at $37.91 with a loss of -4.34% for the day. The stock had closed at $39.63 on the previous day. The total traded volume was 16,525,037 shares.

The company shares have dropped -22.65% from its 1 Year high price. On Jul 23, 2015, the shares registered one year high at $51.74 and the one year low was seen on Jan 28, 2016. The 50-Day Moving Average price is $38.29 and the 200 Day Moving Average price is recorded at $40.41.

Stocks of Abbott Laboratories (NYSE:ABT) rallied by 1.39% during the past week but lost 3.54% on a 4-week basis. The company has outperformed the S&P 500 by 3.07% in the past week but underperformed the index by 0.62% in the last 4 weeks.

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a range of health care products. Abbott operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment includes the sales of a line of adult and pediatric nutritional products. The Nutritional Products includes the sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary, endovascular, structural heart, vessel closure and other medical device products.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.